HMGB1 and Stroke: In summary, our data here suggest that post-stroke EE improves stroke outcomes in an apparently pro-angiogenesis manner through astrocytic HMGB1-mediated inhibition of PSD and PSA, and also through astrocytic HMGB1-induced production and secretion of IL-6 from activated astrocytes.